XASX
AJX
Market cap13mUSD
Oct 09, Last price
0.01AUD
1D
0.00%
1Q
0.00%
Jan 2017
-98.71%
Name
Alexium International Group Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Alexium International Group Limited is a U.S.-based firm specializing in the production and distribution of phase-change materials (PCM) and various advanced textile technologies. The company's portfolio includes a range of thermal management solutions such as Alexicool, a PCM-based chemical finish for fabrics; Biocool, which delivers natural and bio-derived PCM cooling for both textile and foam bedding; and Eclipsys, an ongoing cooling innovation designed to enhance comfort in bedding systems. Additionally, Alexium provides fire-resistant treatments like Alexiflam, engineered to impart flame retardancy to cotton, linen, other cellulosic textiles, and mattresses. Its key markets encompass the bedding, military, and workwear industries. Founded in 1994, the company's operations are headquartered in Greer, South Carolina.
Key people
Simon Moore
Interim Non-Executive Independent Chairman of the Board · since 2023
William Blackburn
Chief Executive Officer, Managing Director, Executive Director · since 2022
Robert Brookins
Chief Technology Officer, Executive Director · since 2022
Mark Licciardo
Company Secretary · since 2020
T. Randall Lane
Non-Executive Director · since 2024
Martyn Strickland
Non-Executive Director · since 2024
James Williamson
Non-Executive Director · since 2024
Paul Stenson
Independent Non-Executive Director · since 2020
IPO date
Dec 22, 1999
Employees
319
Domiciled in
AU
Incorporated in
AU
Legal address
Level 11-125,St Georges Terrace
Perth, WA 6000
AU
Perth, WA 6000
AU
Headquarters
Level 11 125,St Georges Terrace
Perth, WA 6000
AU
Perth, WA 6000
AU
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||